Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa
ABSTRACT Pseudomonas aeruginosa is the most common pathogen infecting the lungs of people with cystic fibrosis (CF), causing both acute and chronic infections. Intrinsic and acquired antibiotic resistance, coupled with the physical barriers resulting from desiccated CF sputum, allow P. aeruginosa to...
Main Authors: | Ronan A. Murphy, Matthew Coates, Sophia Thrane, Akshay Sabnis, James Harrison, Silke Schelenz, Andrew M. Edwards, Thomas Vorup-Jensen, Jane C. Davies |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2022-08-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.00813-22 |
Similar Items
-
Repurposing Mitomycin C in Combination with Pentamidine or Gentamicin to Treat Infections with Multi-Drug-Resistant (MDR) <i>Pseudomonas aeruginosa</i>
by: Elin Svedholm, et al.
Published: (2024-02-01) -
Repurposing High-Throughput Screening Identifies Unconventional Drugs with Antibacterial and Antibiofilm Activities against Pseudomonas aeruginosa under Experimental Conditions Relevant to Cystic Fibrosis
by: Giovanni Di Bonaventura, et al.
Published: (2023-08-01) -
Antibiotic Resistance in Patients with Cystic Fibrosis: Past, Present, and Future
by: Evanthia P. Perikleous, et al.
Published: (2023-01-01) -
Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms
by: Leisha M. Armijo, et al.
Published: (2020-02-01) -
Involvement of Acquired Tobramycin Resistance in the Shift to the Viable but Non-Culturable State in <i>Pseudomonas aeruginosa</i>
by: Gianmarco Mangiaterra, et al.
Published: (2023-07-01)